Geerts A - Search Results

1

Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages^☆.

Lefere S, Puengel T, Hundertmark J, Penners C, Frank AK, Guillot A, de Muynck K, Heymann F, Adarbes V, Defrêne E, Estivalet C, Geerts A, Devisscher L, Wettstein G, Tacke F. Lefere S, et al. Among authors: geerts a. J Hepatol. 2020 Oct;73(4):757-770. doi: 10.1016/j.jhep.2020.04.025. Epub 2020 Apr 29. J Hepatol. 2020. PMID: 32360434

2

Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice.

Louis H, Van Laethem JL, Wu W, Quertinmont E, Degraef C, Van den Berg K, Demols A, Goldman M, Le Moine O, Geerts A, Devière J. Louis H, et al. Among authors: geerts a. Hepatology. 1998 Dec;28(6):1607-15. doi: 10.1002/hep.510280621. Hepatology. 1998. PMID: 9828225

3

Decreased leukocyte recruitment in the mesenteric microcirculation of rats with cirrhosis is partially restored by treatment with peginterferon: an in vivo study.

Geerts AM, Cheung KJ, Van Vlierberghe H, De Vriese AS, Mortier S, Vanheule E, Lameire N, De Vos M, Colle I. Geerts AM, et al. J Hepatol. 2007 May;46(5):804-15. doi: 10.1016/j.jhep.2006.11.014. Epub 2006 Dec 15. J Hepatol. 2007. PMID: 17275128

4

Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice.

Van Steenkiste C, Ribera J, Geerts A, Pauta M, Tugues S, Casteleyn C, Libbrecht L, Olievier K, Schroyen B, Reynaert H, van Grunsven LA, Blomme B, Coulon S, Heindryckx F, De Vos M, Stassen JM, Vinckier S, Altamirano J, Bataller R, Carmeliet P, Van Vlierberghe H, Colle I, Morales-Ruiz M. Van Steenkiste C, et al. Among authors: geerts a. Hepatology. 2011 May;53(5):1629-40. doi: 10.1002/hep.24238. Hepatology. 2011. PMID: 21520176

5

Effect of prolyl hydroxylase domain-2 haplodeficiency on the hepatocarcinogenesis in mice.

Heindryckx F, Kuchnio A, Casteleyn C, Coulon S, Olievier K, Colle I, Geerts A, Libbrecht L, Carmeliet P, Van Vlierberghe H. Heindryckx F, et al. Among authors: geerts a. J Hepatol. 2012 Jul;57(1):61-8. doi: 10.1016/j.jhep.2012.02.021. Epub 2012 Mar 13. J Hepatol. 2012. PMID: 22420978

6

Inhibition of the placental growth factor decreases burden of cholangiocarcinoma and hepatocellular carcinoma in a transgenic mouse model.

Heindryckx F, Bogaerts E, Coulon SH, Devlies H, Geerts AM, Libbrecht L, Stassen JM, Carmeliet P, Colle IO, Van Vlierberghe HR. Heindryckx F, et al. Eur J Gastroenterol Hepatol. 2012 Sep;24(9):1020-32. doi: 10.1097/MEG.0b013e3283554219. Eur J Gastroenterol Hepatol. 2012. PMID: 22772092

7

The placental growth factor as a target against hepatocellular carcinoma in a diethylnitrosamine-induced mouse model.

Heindryckx F, Coulon S, Terrie E, Casteleyn C, Stassen JM, Geerts A, Libbrecht L, Allemeersch J, Carmeliet P, Colle I, Van Vlierberghe H. Heindryckx F, et al. Among authors: geerts a. J Hepatol. 2013 Feb;58(2):319-28. doi: 10.1016/j.jhep.2012.09.032. Epub 2012 Oct 6. J Hepatol. 2013. PMID: 23046674

8

Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models.

Coulon S, Legry V, Heindryckx F, Van Steenkiste C, Casteleyn C, Olievier K, Libbrecht L, Carmeliet P, Jonckx B, Stassen JM, Van Vlierberghe H, Leclercq I, Colle I, Geerts A. Coulon S, et al. Among authors: geerts a. Hepatology. 2013 May;57(5):1793-805. doi: 10.1002/hep.26219. Epub 2013 Mar 14. Hepatology. 2013. PMID: 23299577

9

Therapeutic effects of artesunate in hepatocellular carcinoma: repurposing an ancient antimalarial agent.

Vandewynckel YP, Laukens D, Geerts A, Vanhove C, Descamps B, Colle I, Devisscher L, Bogaerts E, Paridaens A, Verhelst X, Van Steenkiste C, Libbrecht L, Lambrecht BN, Janssens S, Van Vlierberghe H. Vandewynckel YP, et al. Among authors: geerts a. Eur J Gastroenterol Hepatol. 2014 Aug;26(8):861-70. doi: 10.1097/MEG.0000000000000066. Eur J Gastroenterol Hepatol. 2014. PMID: 24987823

10

Time-dependent effect of hypoxia on tumor progression and liver progenitor cell markers in primary liver tumors.

Bogaerts E, Heindryckx F, Devisscher L, Paridaens A, Vandewynckel YP, Van den Bussche A, Verhelst X, Libbrecht L, van Grunsven LA, Geerts A, Van Vlierberghe H. Bogaerts E, et al. Among authors: geerts a. PLoS One. 2015 Mar 20;10(3):e0119555. doi: 10.1371/journal.pone.0119555. eCollection 2015. PLoS One. 2015. PMID: 25793288 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

360 results

Search Page